Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies. - Lopez-Tarruella S; Pollán M; Carrasco E; Andrés R; Martín M; Servitja S; Bermejo B; Antón A; Guerrero-Zotano Á; Muñoz M; Fernández L; Martínez Del Prado P; et al. (The oncologist, 2025)